RCEL
AVITA Medical Inc

1,132
Mkt Cap
$154.08M
Volume
197,365.00
52W High
$10.29
52W Low
$3.22
PE Ratio
-2.87
RCEL Fundamentals
Price
$5.03
Prev Close
$5.11
Open
$5.00
50D MA
$3.95
Beta
1.47
Avg. Volume
225,579.05
EPS (Annual)
-$1.74
P/B
-9.24
Rev/Employee
$316,858.41
$123.98
Loading...
Loading...
News
all
press releases
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
The consensus price target hints at a 29.9% upside potential for Avita Medical (RCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Analysts
Shares of Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) have been given a consensus rating of "Hold" by the five research firms that are presently covering the firm, Marketbeat.com reports. One...
MarketBeat·5d ago
News Placeholder
Avita Medical Targets Progressive 2026 Growth, Guides $80M-$85M Revenue After Headwind Year
Avita Medical (NASDAQ:RCEL) executives told investors they are focused on making the business more predictable and execution-driven in 2026, following what they described as a headwind-heavy 2025...
MarketBeat·5d ago
News Placeholder
Insider Buying: Avita Medical (NASDAQ:RCEL) CFO Acquires 3,000 Shares of Stock
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) CFO David O'toole purchased 3,000 shares of the stock in a transaction dated Thursday, February 19th. The stock was purchased at an average price of...
MarketBeat·5d ago
News Placeholder
Avita Medical (NASDAQ:RCEL) CFO David O'toole Purchases 3,000 Shares of Stock
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) CFO David O'toole acquired 3,000 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was purchased at an...
MarketBeat·6d ago
News Placeholder
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·10d ago
News Placeholder
Avita Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital
D. Boral Capital reiterated a "buy" rating and set a $10.00 target price on shares of Avita Medical in a research report on Tuesday...
MarketBeat·12d ago
News Placeholder
Avita Medical Q4 Earnings Call Highlights
Avita Medical (NASDAQ:RCEL) reported fourth-quarter revenue of $17.6 million and full-year 2025 revenue of approximately $71.6 million, representing about 11% growth over 2024 and landing in line...
MarketBeat·17d ago
News Placeholder
Avita Medical (NASDAQ:RCEL) Issues Earnings Results, Misses Expectations By $0.02 EPS
Avita Medical (NASDAQ:RCEL - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates...
MarketBeat·17d ago
News Placeholder
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday
Avita Medical (NASDAQ:RCEL) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 12. (View Earnings Report at...
MarketBeat·25d ago
<
1
2
...
>

Latest RCEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.